Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer

Serum leptin: A marker of prostate cancer irrespective of obesity

(2017) S.K. Singh et al.   Cancer Biomarkers

Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials

(2012) Hai T Tran et al.   LANCET ONCOLOGY

A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma

(2011) A. J. Zurita et al.   ANNALS OF ONCOLOGY

Leptin Levels in Thyroid Cancer

(2010) Melih Akinci et al.   Asian Journal of Surgery

Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma

(2010) Shih-Ping Cheng et al.   SURGERY

Circulating levels of leptin, adiposity and breast cancer risk

(2009) M-H Wu et al.   BRITISH JOURNAL OF CANCER

Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma

(2009) Shahab Uddin et al.   ENDOCRINE-RELATED CANCER

The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation

(2008) Ha T T Phan et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY